Merck & Co Inc (NYSE: MRK) kicked off on Tuesday, up 4.84% from the previous trading day, before settling in for the closing price of $86.75. Over the past 52 weeks, MRK has traded in a range of $73.31-$105.07.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 12.04%. While this was happening, its average annual earnings per share was recorded 17.22%. With a float of $2.48 billion, this company’s outstanding shares have now reached $2.49 billion.
Merck & Co Inc (MRK) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Merck & Co Inc is 0.11%, while institutional ownership is 80.91%. The most recent insider transaction that took place on Nov 10 ’25, was worth 616,395. Before that another transaction happened on Nov 03 ’25, when Company’s EVP,Chief Info&Digital Officer sold 8,614 for $83.59, making the entire transaction worth $720,040. This insider now owns 24,578 shares in total.
Merck & Co Inc (MRK) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 1.72 earnings per share (EPS), higher than consensus estimate (set at 1.67) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.20% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Take a look at Merck & Co Inc’s (MRK) current performance indicators. Last quarter, stock had a quick ratio of 1.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.53. Likewise, its price to free cash flow for the trailing twelve months is 17.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.56, a number that is poised to hit 2.06 in the next quarter and is forecasted to reach 9.37 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Compared to the last year’s volume of 14.53 million, its volume of 10.6 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 83.36%.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 99.20%, which indicates a significant increase from 98.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.14 in the past 14 days, which was higher than the 1.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $84.75, while its 200-day Moving Average is $84.11. Nevertheless, the first resistance level for the watch stands at $92.26 in the near term. At $93.56, the stock is likely to face the second major resistance level. The third major resistance level sits at $96.06. If the price goes on to break the first support level at $88.45, it is likely to go to the next support level at $85.95. Should the price break the second support level, the third support level stands at $84.65.
Merck & Co Inc (NYSE: MRK) Key Stats
The company with the Market Capitalisation of 225.74 billion has total of 2,482,023K Shares Outstanding. Its annual sales at the moment are 64,168 M in contrast with the sum of 17,117 M annual income. Company’s last quarter sales were recorded 17,276 M and last quarter income was 5,785 M.
